BioSpace News Archive

Career Advice

8 Reasons Building “Internal Network” Is Good for Your Career

Building an “Internal Network” is much the same as regular professional networking. Look at some of the reasons why it is important in contemporary times.

November 13, 2018
·
3 min read
·
Editorial Staff
Business

The Hydroponics Company Ltd (ASX:THC) Quarterly Update

The Hydroponics Company Limited, to be renamed THC Global Group Limited is pleased to provide an update to the market of its activities for the quarter ended 30 September 2018 (the Quarter).

November 13, 2018
·
4 min read
Policy

Pain Therapeutics Will Make the Case for an FDA Reversal on Remoxy

Texas-based Pain Therapeutics is urging the FDA to reconsider the Complete Response Letter it issued in August for the company’s opioid-treatment, Remoxy. Representatives from Pain Therapeutics will meet with the FDA on Jan. 31. 2019 to discuss the request, the company announced late Monday.

November 13, 2018
·
2 min read
·
Alex Keown
Career Advice

5 Advantages of Looking for a New Job Over the Holidays

Many job seekers take it for granted that the holidays are not the best time to be on the job market, so they suspend their job hunt until after the new year. Others get distracted by all of the holiday hullabaloo and don’t put as much time and effort into their search as they need to.

November 13, 2018
·
2 min read
·
Editorial Staff
Drug Development

Where Are They Now? Top 3 Biotech Startups From NextGen Bio 2016

Every year, BioSpace analyzes the biotech industry, looking for the hot new biotech startups to watch. Here’s a look at the top 3 companies from the Top 20 Life Science Startups to Watch in the U.S. from 2016.

November 13, 2018
·
4 min read
·
Mark Terry
Business

Anatara Lifesciences Ltd (ASX:ANR) Quarterly Report

Anatara Lifesciences is pleased to release its Appendix 4C for the quarter ending 30th September 2018. The Company’s cash position at the end of the quarter stood at $7.1m.

November 13, 2018
·
2 min read
Business

Nanollose Ltd (ASX:NC6) Quarterly Update

Nanollose Limited is pleased to provide its Appendix 4C cash flow statement for the quarter ending 30 September 2018, together with the following operational update.

November 13, 2018
·
4 min read
Deals

Nestlé Increases Stake in Aimmune as Company Eyes Filing for FDA Approval of Peanut Allergy Medicine

As California-based Aimmune prepares to seek regulatory approval for its peanut allergy treatment, AR101, Nestlé Health Science has increased its financial stake in the food allergy prevention-focused company with another $98 million investment.

November 13, 2018
·
3 min read
·
Alex Keown
Biotech Bay

California Sees Strong Growth in Its Life Sciences Sector, Survey Shows

California saw a 4.2 percent growth of jobs, about 12,500 in total, according to the latest report from the California Life Sciences Association.

November 13, 2018
·
2 min read
·
Alex Keown
Pharm Country

Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardiovascular Health

Viagra (sildenafil), Pfizer’s blockbuster drug for erectile dysfunction, is a classic example of how a drug developed for one thing can turn out to be successful for another.

November 13, 2018
·
4 min read
·
Mark Terry